FDA Notices Shah Rukh, Ajay Devgn, Tiger Shroff Over Pan Masala Ads

The Food and Drug Administration (FDA) has issued a show cause notice to prominent Bollywood actors Shah Rukh Khan, Ajay Devgn, and Tiger Shroff for their involvement in advertisements for Vimal Elaichi.

The FDA alleges that these advertisements are actually a masked promotion of Vimal Pan Masala, which is prohibited in the state of Maharashtra. The notice instructs the actors to immediately stop their promotional activities for the brand and remove any existing advertisements.

The actors have been given fifteen days to provide details about the due diligence they conducted before endorsing the brand and to share their endorsement contracts with the FDA. This move by the FDA is an attempt to curb the promotion of banned products in the state.

The Vimal Pan Masala brand has been banned in Maharashtra due to its harmful effects on health. The FDA has been cracking down on companies that try to circumvent the ban by promoting similar products with different names.

The involvement of prominent actors in the promotion of these products has raised concerns about the impact of celebrity endorsements on consumer behavior. The FDA's action against the actors is seen as a step towards protecting the public from harmful products.

Shah Rukh Khan, Ajay Devgn, and Tiger Shroff are yet to respond to the notice. The outcome of this case will be closely watched, as it may set a precedent for future cases involving celebrity endorsements of banned products.

The FDA's move is part of a larger effort to regulate the promotion of food products in the state. The agency has been working to ensure that companies comply with food safety regulations and do not mislead consumers through deceptive advertising.

In recent years, there has been a growing concern about the impact of pan masala on public health. The product has been linked to several health problems, including oral cancer and other diseases. The ban on Vimal Pan Masala in Maharashtra is an attempt to reduce the consumption of this product and promote public health.

The case against the actors is a significant development in the FDA's efforts to regulate the promotion of banned products. It remains to be seen how the actors will respond to the notice and what action the FDA will take next.

The FDA's action is a reminder that celebrity endorsements can have a significant impact on consumer behavior. It also highlights the need for companies and celebrities to ensure that they are promoting safe and legal products.

In conclusion, the FDA's notice to Shah Rukh Khan, Ajay Devgn, and Tiger Shroff is an important step towards protecting the public from harmful products. The outcome of this case will be closely watched, and it may have significant implications for the regulation of celebrity endorsements in the future.